Rankings
▼
Calendar
TKNO FY 2019 Earnings — Alpha Teknova, Inc. Revenue & Financial Results | Market Cap Arena
TKNO
Alpha Teknova, Inc.
$135M
FY 2019 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$20M
Gross Profit
$9M
42.7% margin
Operating Income
-$2M
-9.2% margin
Net Income
-$1M
-6.5% margin
EPS (Diluted)
$-0.36
Cash Flow
Operating Cash Flow
$2M
Free Cash Flow
-$477,000
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$59M
Total Liabilities
$46M
Stockholders' Equity
$13M
Cash & Equivalents
$4M
← Q1 2020
All Quarters